Tag Archives: 510k

CXM Cardium Therapeutics inc, is still waiting to hear from the FDA , The company, submitted a 510(k) premarket notification filing with the U.S. Food and Drug Administration (FDA) seeking marketing clearance of its Excellagen product candidate on the 4-Dec-2009. Although the FDA never give a guide line to 510k dates the markets usually look [...]